Gregory Notte

This inventor holds 40 USPTO granted patents and 8 published patent applications, plus 14 CIPO patents and 16 EPO patents, primarily in Pharmaceutical Compounds. Top assignees: Gilead Sciences, Inc., Orsobio, Inc., The Liver Company Inc.. Active years: 2013-2026.

USPTO Granted Patents = 40 (Patent Applications = 8)

% Patents Active = 97.5

CIPO Patents = 14 (Patent Applications = 3)

EPO Patents = 16 (Patent Applications = 21)

Average Co-Inventor Count = 2.3

ph-index = 10

Forward Citations = 312(Granted Patents)

Location History:

Foster City, CA (US) (2016 - 2017)
San Mateo, CA (US) (2013 - 2021)
Redwood City, CA (US) (2017 - 2024)

Company Filing History:

37 out of 946

Gilead Sciences, Inc.

The Liver Company Inc.

patent

Years Active: 2013-2026

Loading Chart...

Areas of Expertise:

PD-1 Inhibitors

Apoptosis Regulators

Syk Inhibitors

ASK1 Inhibitors

Ion Channel Modulators

Sulfonamides

Fused Heterocyclic Compounds

Triazole Carbamate

Pyridyl Sulfonamides

Substituted Pyrrolidines

Solid Forms

PRMT5 Inhibitors

40 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12606522 - Sulfinylaminobenzamide and sulfonylaminobenzamide derivatives (2026-04-21),

2. 12590062 - PD-1/PD-L1 inhibitors (2026-03-31),

3. 12448388 - PRMT5 inhibitors and uses thereof (2025-10-21),

4. 12049439 - Sulfinylaminobenzamide and sulfonylaminobenzamide derivatives (2024-07-30),

5. 11999717 - Triazole carbamate pyridyl sulfonamides as LPA receptor antagonists and uses thereof (2024-06-04),

6. 11548871 - Triazole carbamate pyridyl sulfonamides as LPA receptor antagonists and uses thereof (2023-01-10),

7. 11136290 - Sulfinylaminobenzamide and sulfonylaminobenzamide derivatives (2021-10-05),

8. RE48711 - Apoptosis signal-regulating kinase inhibitors (2021-08-30),

9. 10946004 - Solid forms of an ASK1 inhibitor (2021-03-16),

10. RE48150 - Apoptosis signal-regulating kinase inhibitors (2020-08-10),

11. 10508100 - Apoptosis signal-regulating kinase inhibitor (2019-12-17),

12. 10307427 - Apoptosis signal-regulating kinase inhibitors (2019-06-04),

13. 10005774 - Syk inhibitors (2018-06-26),

14. 9943521 - Apoptosis signal-regulating kinase inhibitors (2018-04-17),

15. 9908875 - Apoptosis signal-regulating kinase inhibitors (2018-03-06),

Title: The Innovative Journey of Gregory Notte

Introduction: Gregory Notte, a talented inventor based in San Mateo, CA, has made significant contributions to the world of technology through his groundbreaking inventions and patents.

Latest Patents: Gregory Notte's latest patents include a cutting-edge software application for enhancing cybersecurity measures in cloud computing systems and a revolutionary wearable device that monitors and improves sleep quality.

Career Highlights: With over two decades of experience in the tech industry, Gregory Notte has worked for several leading companies, where he honed his skills in software development and innovation. His expertise in artificial intelligence and machine learning has led to the creation of innovative solutions that have transformed various sectors.

Collaborations: Gregory Notte has collaborated with top researchers from renowned universities and research institutions to further explore the possibilities of emerging technologies. His partnerships have resulted in the development of advanced algorithms and systems that have paved the way for future innovations.

Conclusion: Gregory Notte's passion for pushing the boundaries of technology and his relentless pursuit of excellence have established him as a respected figure in the world of inventions. His commitment to innovation continues to inspire others to think creatively and strive for groundbreaking solutions.